Lipocine expects trial data to support a 505(b)(2) new drug application submission for LPCN 1154 in 2026.

RE104 is a proprietary, potential best-in-class, patented prodrug of 4-OH-DiPT, which is administered via a single subcutaneous injection. Reunion designed RE104 to deliver a short, acute psychoactive ...

Persistent sadness after the birth of your baby is a reason to consult a doctor or mental health professional. Untreated postpartum depression can be risky for you and your newborn. The “baby blues” ...